Previous 10 | Next 10 |
2023-07-09 18:15:18 ET Acumen Pharmaceuticals ( NASDAQ: ABOS ), Establishment Labs ( NASDAQ: ESTA ), Arcus Biosciences ( NYSE: RCUS ) and BridgeBio Pharma ( NASDAQ: BBIO ) are four of BTIG's top picks for small and mid-cap healthcare stocks going into the lat...
- Phase 3 DISSOLVE I and DISSOLVE II studies both met their primary efficacy endpoints, with SEL-212-treated patients demonstrating statistically significant higher response rates compared to placebo - - SEL-212 was observed to have a favorable safety profile and was well-tolerated acro...
2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...
2023-05-04 19:06:14 ET Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Conference Call May 04, 2023, 08:30 ET Company Participants Blaine Davis - CFO Carsten Brunn - CEO, President & Director Peter Traber - Chief Medical Officer Conference Call Partic...
2023-05-04 07:50:06 ET Selecta Biosciences press release ( NASDAQ: SELB ): Q1 GAAP EPS of -$0.14 misses by $0.05 . Revenue of $5.9M (-82.6% Y/Y) misses by $6.24M . $127.5 million in cash, cash equivalents, restricted cash, and marketable securities as of...
- Company to implement capital prioritization initiative, extending cash runway to 2H-2025 - - $127.5 million in cash, cash equivalents, restricted cash, and marketable securities as of March 31, 2023 - - Reported positive data from Phase 3 DISSOLVE program of SEL-212 ...
WATERTOWN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies for autoimmune diseases and gene therapies, today announced that it plans ...
2023-04-18 17:26:02 ET Summary After one month, the coffee can small cap portfolio has 14 stocks up and 12 stocks down. The biggest gainer over one month was JAKKS Pacific with a 45.8% gain. The biggest drag was Co-Diagnostics with a 43.66% decrease. The coffee can p...
2023-04-08 10:00:00 ET Summary Selecta Biosciences recently announced the results of its DISSOLVE I & II Phase 3 clinical trials for SEL-212, a combination therapy for chronic refractory gout patients. The trials met their primary endpoints, but SEL-212's performance did not c...
2023-03-21 09:01:38 ET Investing in penny stocks can be highly rewarding, but it also comes with significant risks. The high-risk, high-reward nature of penny stocks means potential for significant returns. But they can also lose their entire investment if the stock’s price drops...
News, Short Squeeze, Breakout and More Instantly...
Selecta Biosciences Inc. Company Name:
SELB Stock Symbol:
NASDAQ Market:
Selecta Biosciences Inc. Website:
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta ...
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta ...
– Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesi...